|
gptkbp:instanceOf
|
inhaled corticosteroid
|
|
gptkbp:activeIngredient
|
gptkb:fluticasone_propionate
|
|
gptkbp:alternativeTo
|
gptkb:Flovent_Diskus
gptkb:Flixotide_Evohaler
|
|
gptkbp:approvedBy
|
gptkb:FDA
1994
|
|
gptkbp:ATCCode
|
R03BA05
|
|
gptkbp:brand
|
gptkb:fluticasone_propionate
|
|
gptkbp:broadcastOn
|
Rx only
|
|
gptkbp:compatibleWith
|
acute asthma attacks
|
|
gptkbp:contains
|
hydrofluoroalkane propellant
|
|
gptkbp:contraindication
|
hypersensitivity to fluticasone
|
|
gptkbp:drugClass
|
gptkb:Corticosteroid
|
|
gptkbp:form
|
aerosol
metered-dose inhaler
110 mcg
220 mcg
44 mcg
|
|
gptkbp:genericAvailable
|
no (as of 2024)
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Flovent HFA
|
|
gptkbp:manufacturer
|
GlaxoSmithKline
|
|
gptkbp:marketedIn
|
gptkb:Canada
gptkb:United_Kingdom
gptkb:United_States
|
|
gptkbp:mechanismOfAction
|
reduces airway inflammation
|
|
gptkbp:pregnancyCategory
|
C (US)
|
|
gptkbp:prescribes
|
adolescents
adults
children
|
|
gptkbp:prescriptionRequired
|
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020786s056lbl.pdf
|
|
gptkbp:prescriptionStatus
|
prescription only
|
|
gptkbp:replacedBy
|
gptkb:Flovent_CFC
|
|
gptkbp:routeOfAdministration
|
inhalation
|
|
gptkbp:sideEffect
|
headache
cough
oral thrush
hoarseness
|
|
gptkbp:storage
|
room temperature
|
|
gptkbp:usedFor
|
asthma
|
|
gptkbp:bfsParent
|
gptkb:Flovent
|
|
gptkbp:bfsLayer
|
7
|